Filter
1073
Filtered Results: 1073
Text search:
Y.
Ono
Featured
Recommendations
92
New Publications
195
Language
Document type
No document type
407
Guidelines
298
Studies & Reports
158
Manuals
83
Strategic & Response Plan
58
Training Material
26
Fact sheets
23
Brochures
8
Situation Updates
6
Infographics
4
App
1
Resource Platforms
1
Countries / Regions
Latin America and the Carribbean
90
Paraguay
72
Venezuela
54
Argentina
50
Colombia
49
Global
36
Peru
27
Chile
24
Bolivia
23
Ecuador
22
El Salvador
18
Nigeria
16
Spain
13
Kenya
10
Senegal
10
Western and Central Europe
10
Brazil
10
Africa
9
Zambia
9
Uganda
8
Malawi
7
Ukraine
6
Mozambique
6
Congo, Democratic Republic of
6
West and Central Africa
6
East and Southern Africa
6
India
6
Myanmar / Burma
6
Mexico
5
Rwanda
5
Burkina Faso
5
Germany
5
Eastern Europe
5
Syria
4
Philippines
4
Middle East and North Africa
4
South–East Asia Region
4
South Sudan
4
Guatemala
4
Sierra Leone
3
Haiti
3
Eastern Europe and Central Asia
3
Uruguay
3
South Africa
3
Nicaragua
3
Russia
3
Honduras
3
Angola
3
Nepal
2
Ghana
2
Benin
2
Afghanistan
2
Asia
2
Dominican Republic
2
Guinea-Bissau
2
Tanzania
2
Bangladesh
2
Moldova
2
Ethiopia
2
Indonesia
2
Madagascar
2
Tajikistan
1
Switzerland
1
Thailand
1
Kazakhstan
1
Cameroon
1
Kyrgyzstan
1
Burundi
1
Zimbabwe
1
Austria
1
Armenia
1
USA
1
Cambodia
1
Western Pacific Region
1
North America
1
Turkmenistan
1
Mauritius
1
United Kingdom
1
Azerbaijan
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Yemen
1
Palestine
1
Central African Republic
1
Mali
1
Libya
1
Botswana
1
Somalia
1
Liberia
1
Cuba
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
503
Clinical Guidelines
91
Women & Child Health
55
Public Health
43
Key Resources
31
Pharmacy & Technologies
13
Capacity Building
9
Toolboxes
COVID-19
204
TB
129
Mental Health
111
AMR
40
HIV
36
Planetary Health
32
NTDs
31
Rapid Response
28
Disability
28
Caregiver
28
Pharmacy
23
Conflict
20
Zika
15
Cholera
12
Refugee
10
Global Health Education
10
NCDs
9
Ebola
7
Natural Hazards
6
Social Ethics
5
Polio
5
Specific Hazards
2
Health Financing Toolbox
2
This guideline provides advice in regards to applications for Marketing Authorisations for antimicrobial veterinary medicinal products (VMPs) on the data required and the methodology to be used for performing an assessment of the risk to public health from antimicrobial resistance (AMR) due to use o...
Over the reporting period, economic actors continued to carry out their activities with little regard for their impacts on the livelihoods of the communities living in the surrounding areas. In Doo Tha Htoo (Thaton) District, cold dust from a Tatmadaw-run cement factory contaminated nearby waterways...
Accessed on 09.03.2020
Le but de ce guide d’animation est de soutenir les organisations de défense des droits de l’enfant dans leur travail sur les programmes de santé sensibles au genre. Les séances de formation sont conçues pour faciliter la participation des professionnels de la santé...
16.7.2021
Water, sanitation, hygiene, and waste management for SARS-CoV-2, the virus that causes COVID-19
recommended
Updated Interim guidance 29 July 2020
The provision of safe water, sanitation and waste management and hygienic conditions is essential for preventing and for protecting human health during all infectious disease outbreaks, including of coronavirus disease 2019 (COVID-19). Ensuring evidenced-based ...
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib...
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion...
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
Algorithm for COVID-19 triage and referral
recommended
Efficient triage of patients with COVID-19 at all health facility levels (primary, secondary and tertiary) will help the national response planning and case management system cope with patient influx, direct necessary medical resources to efficiently support the critically ill and protect the safety...
The Feedback Starter-Kit responds to key questions ( ) and provides the most important tips ( ) for setting up and running a simple feedback mechanism. At the end of this document there is an overview of the templates needed to plan the mechanism and collect, answer, analyse and share community feed...
Geographical Paper No. 177
Accessed on: 18.06.2020
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
In this document, recommendations are provided on designing and implementing
a cross-sectional serosurvey using school-based sampling to estimate age-specific
DENV seroprevalence to inform a country’s national dengue vaccination program.
The document includes recommendations for methods for ...
Le suivi évaluation des interventions en santé passe par une meilleure lisibilité de l’analyse situationnelle. Une capitalisation du niveau d’atteintes des indicateurs est nécessaire pour traduire la situation sanitaire. Le présent tableau de bord de santé décrit cette situation à traver...
Prevention, identification and management of health worker infection in the context of COVID-19
recommended
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
This report presents examples from different agencies on how they approached community engagement in their Covid-19 responses, the tools and methodologies used, as well as the challenges they encountered and how they attempted to overcome these. It discusses what community engagement means to the va...
